Clinical Trial Update: Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) [NA]

View source ↗

Summary

Completed clinical trial TIME studied targeted self-management for epilepsy and serious mental illness; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Major Depressive Disorder
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Case Western Reserve University | Conditions: Epilepsy, Schizophrenia | NA | Status: COMPLETED | Results posted: 2022-09-28